Enlivex Ltd. (ENLV)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-09-25 | Phase1 Readout | — |
| 2027-02-01 | Phase2 Readout | — |
Active Clinical Trials (3)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06233474 | Study of Intra-articular Allocetra in Knee Osteoarthritis | PHASE2 | Active Not Recruiting | 160 |
| NCT07580716 | Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis | PHASE2 | Recruiting | 270 |
| NCT06208241 | Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety | PHASE1 | Active Not Recruiting | 18 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.